|   Ac-Lys-Val-Cit-PABC-MMAE structure | Common Name | Ac-Lys-Val-Cit-PABC-MMAE | ||
|---|---|---|---|---|
| CAS Number | 1650569-89-3 | Molecular Weight | 1293.64 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C66H108N12O14 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of Ac-Lys-Val-Cit-PABC-MMAEAc-Lys-Val-Cit-PABC-MMAE is a drug-linker conjugate for ADC. Ac-Lys-Val-Cit-PABC-MMAE contains the ADC linker (peptide Ac-Lys-Val-Cit-PABC) and a potent tubulin polymerization inhibitor MMAE (HY-15162)[1]. | 
| Name | Ac-Lys-Val-Cit-PABC-MMAE | 
|---|
| Description | Ac-Lys-Val-Cit-PABC-MMAE is a drug-linker conjugate for ADC. Ac-Lys-Val-Cit-PABC-MMAE contains the ADC linker (peptide Ac-Lys-Val-Cit-PABC) and a potent tubulin polymerization inhibitor MMAE (HY-15162)[1]. | 
|---|---|
| Related Catalog | |
| Target | Auristatin | 
| References | [1]. Kleniman, et al. Engineered polypeptide conjugates. WO2015015448A2. | 
| Molecular Formula | C66H108N12O14 | 
|---|---|
| Molecular Weight | 1293.64 |